Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Mexico
  4. Mexican Stock Exchange
  5. Genomma Lab Internacional, S.A.B. de C.V.
  6. Summary
    LAB B   MX01LA010006

GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.

(LAB B)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Mexican Stock Exchange
01/12/2022 01/13/2022 01/14/2022 01/17/2022 01/18/2022 Date
20.73 20.53 20.38 19.75 19.57 Last
6750252 1285177 1570286 460709 1745501 Volume
+1.47% -0.96% -0.73% -3.09% -0.91% Change
Estimated financial data (e)
Sales 2021 14 745 M 720 M 720 M
Net income 2021 1 611 M 78,7 M 78,7 M
Net Debt 2021 3 726 M 182 M 182 M
P/E ratio 2021 12,8x
Yield 2021 1,46%
Sales 2022 16 264 M 794 M 794 M
Net income 2022 2 086 M 102 M 102 M
Net Debt 2022 3 291 M 161 M 161 M
P/E ratio 2022 10,0x
Yield 2022 2,92%
Capitalization 19 692 M 963 M 962 M
EV / Sales 2021 1,59x
EV / Sales 2022 1,41x
Nbr of Employees 2 067
Free-Float 68,2%
More Financials
Company
Genomma Lab Internacional SAB de CV is a Mexico-based over-the-counter pharmaceutical (OTC pharmaceutical), generic drugs (GD) and personal care products company. The Company is engaged in the development, distribution and marketing of a range of products within different brands, for such treatments as anti-acne, varicose vein, hair loss, sexual stimulation and influenza; as well as analgesics and antifungals. The... 
Sector
Pharmaceuticals
Calendar
02/23Earnings Release
More about the company
Ratings of Genomma Lab Internacional, S.A.B. de C.V.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.
2021GENOMMA LAB INTERNACIONAL B DE C : Announces Dividend Payment
PU
2021GENOMMA LAB INTERNACIONAL, S.A.B. DE : Ex-dividend day for interim dividend
FA
2021GENOMMA LAB INTERNACIONAL, S.A.B. DE : Ex-dividend day for interim dividend
FA
2021GENOMMA LAB INTERNACIONAL B DE C : Oramed and Genomma Lab Internacional Announce Joint Ven..
PU
2021Oramed Pharmaceuticals Inc. and Genomma Lab Internacional, S.A.B. de C.V. Announces Joi..
CI
2021Genomma Lab Internacional to Seek Acquisitions
CI
2021TRANCHE UPDATE ON GENOMMA LAB INTERN : LAB B)'s Equity Buyback Plan announced on March 20,..
CI
2021Genomma Lab Q3 2021 Earnings Release
PU
2021Genomma Lab Internacional, S.A.B. de C.V. Reports Earnings Results for the Third Quarte..
CI
2021GENOMMA LAB INTERNACIONAL B DE C : 3Q-2021 Earnings Call Advisory
PU
2021GENOMMA LAB INTERNACIONAL B DE C : Receives Good Manufacturing Practices (GMP) Certificati..
PU
2021GENOMMA LAB INTERNACIONAL B DE C : External Auditor Ratification
PU
2021GENOMMA LAB INTERNACIONAL B DE C : Q2 2021 Earnings Release
PU
2021Genomma Lab Internacional, S.A.B. De C.V. Reports Earnings Results for the Second Quart..
CI
2021TRANCHE UPDATE ON GENOMMA LAB INTERN : LAB B)'s Equity Buyback Plan announced on March 20,..
CI
More news
News in other languages on GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.
2021GENOMMA LAB INTERNACIONAL B DE C : Pago de dividendos
2021GENOMMA LAB INTERNACIONAL B DE C : y Oravax Medical, anuncian Alianza Estratégica para Des..
2021Constancia del 3er Trimestre de 2021
2021Genomma Lab Reporte de Resultados 3T 2021
2021GENOMMA LAB INTERNACIONAL B DE C : 3T-2021 Invitación a Conferencia de Resultados
More news
Chart GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.
Duration : Period :
Genomma Lab Internacional, S.A.B. de C.V. Technical Analysis Chart | LAB B | MX01LA010006 | MarketScreener
Technical analysis trends GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 19,57 MXN
Average target price 26,18 MXN
Spread / Average Target 33,8%
EPS Revisions
Managers and Directors
Jorge Luis Brake Valderrama Chief Executive Officer
Antonio Zamora Galland Vice President-Administration & Finance
Rodrigo Alonso Herrera Aspra Chairman
Marco Sparvieri Chief Operating Officer & Executive Vice President
Juan Alonso Independent Director
Sector and Competitors
1st jan.Capi. (M$)
GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.-8.89%966
JOHNSON & JOHNSON-2.32%439 907
ROCHE HOLDING AG-3.75%322 066
PFIZER, INC.-8.37%303 712
ABBVIE INC.1.02%241 811
ELI LILLY AND COMPANY-10.55%223 992